Eben Rosenthal
Clinical trials sponsored by Eben Rosenthal, explained in plain language.
-
Glow-in-the-Dark dye could help surgeons spot brain tumors
Diagnosis Recruiting nowThis early-stage trial tests a fluorescent dye called panitumumab-IRDye800 that attaches to cancer cells. Before surgery, 30 adults with brain tumors will receive a single infusion of the dye. During their operation, a special camera will detect the dye's glow, helping surgeons d…
Phase: EARLY_PHASE1 • Sponsor: Eben Rosenthal • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC
-
New scan could spot hidden cancer spread in head and neck patients
Diagnosis Recruiting nowThis study tests a new imaging agent called 89Zr panitumumab to see if it can more accurately find cancer that has spread in people with head and neck cancer. Standard PET/CT scans often miss or wrongly identify these spots. About 60 participants will receive the new agent and th…
Phase: PHASE1 • Sponsor: Eben Rosenthal • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Glow-in-the-Dark drug could help surgeons spot brain cancer
Knowledge-focused Recruiting nowThis early-phase trial tests a special version of the immunotherapy drug nivolumab that has a fluorescent dye attached (nivo800). The dye makes the drug glow under near-infrared light, allowing researchers to see exactly where the drug goes in the tumor during surgery. About 38 a…
Phase: EARLY_PHASE1 • Sponsor: Eben Rosenthal • Aim: Knowledge-focused
Last updated Jul 02, 2026 02:00 UTC